Home › Funds › Omega Fund Management, LLC › ENGN

Omega Fund Management, LLC position in ENGN

ENGENE THERAPEUTICS INC · Health Care

Omega Fund Management, LLC reported holding 876,357 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.5M, representing 0.82% of its reported portfolio and ranking #9 among its reported holdings. Omega Fund Management, LLC has disclosed ENGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)876.36K sh
Reported value held$1.52M
Portfolio Weight0.82%
First reportedQ4 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Omega Fund Management, LLC's ENGN position evolved

Omega Fund Management, LLC first disclosed a stake in ENGN in Q4 2023 at 1,131,175 shares (US$10.4M). The position peaked in Q1 2024 at 1,076,357 shares, worth US$18.2M. Across 11 filings, Omega Fund Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 876,357 shares valued at US$1.5M. Notable position changes include a 51% trim in Q4 2024 (shares fell 33% over the following quarter), a 66% increase in Q4 2025 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.13M $10.44M New
Q1 2024 1.08M $18.24M Reduce
Q2 2024 1.08M $10.15M Hold
Q3 2024 1.08M $7.10M Hold
Q4 2024 526.36K $3.50M Reduce
Q1 2025 526.36K $2.36M Hold
Q2 2025 526.36K $1.92M Hold
Q3 2025 526.36K $3.60M Hold
Q4 2025 876.36K $7.91M Add
Q1 2026 876.36K $5.97M Hold
Q2 2026 876.36K $1.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENGN and 13F data

ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENGN

All ENGN fund holders →

FAQ

How long has Omega Fund Management, LLC held ENGN?

Omega Fund Management, LLC has disclosed ENGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Omega Fund Management, LLC's current position in ENGN?

As of Q2 2026, Omega Fund Management, LLC holds 876.36K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $1.52M, representing 0.82% of its reported portfolio and ranking #9.

Has Omega Fund Management, LLC been buying or selling ENGN?

In the latest 13F filing (Q2 2026), Omega Fund Management, LLC held unchanged its position in ENGN. The position peaked in Q1 2024 at 1.08M shares.

Which other funds hold ENGN?

Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.